US approves sickle cell breakthrough with gene editing therapy

by

The United States on Friday approved a breakthrough medicine that uses revolutionary gene editing tool CRISPR to treat the debilitating blood disorder sickle cell disease.

Leave A Comment

Your email address will not be published. Required fields are marked *